Results 131 to 140 of about 47,442 (285)

Incidence and predictors of transthyretin cardiac amyloidosis in patients with degenerative aortic stenosis [PDF]

, 2022
Bryan Abadie, M Held, Rishi Puri, Amar Krishnaswamy, James Yun, Mary K. Hanna, Grant W. Reed, Sohum Kapadia, W Jaber   +8 more
openalex   +1 more source

Catheter Ablation and Device Therapy in Patients With Transthyretin Amyloid Cardiomyopathy: A Review of Non‐Pharmacological Therapy

Journal of Arrhythmia, Volume 42, Issue 1, February 2026.
Transthyretin cardiomyopathy (ATTR‐CM) frequently coexists with atrial fibrillation, atrial flutter, and atrial tachycardia as well as occasionally ventricular arrhythmias and often conduction abnormalities, necessitating management for arrhythmias. Therefore, for arrhythmia specialists, the ability to diagnose ATTR‐CM and proficiency in arrhythmia ...
Hisanori Kanazawa, Tadashi Hoshiyama, Shozo Kaneko, Yusei Kawahara, Yuichiro Tsuruta, Yuta Tsurusaki, Kohei Matsunaga, Shunsuke Tamanoi, Naoto Kuyama, Hiroki Usuku, Eiichiro Yamamoto, Yasuhiro Izumiya, Kenichi Tsujita   +12 more
wiley   +1 more source

Diagnostic and therapeutic challenges in rapidly progressing cardiac amyloidosis: a literature review based on case report

International Journal of Emergency Medicine
Introduction Cardiac amyloidosis is a rarely reported and potentially fatal variant of the systemic disease. Its early diagnosis could potentially lead to significantly improved clinical outcomes.
Nahid Senobari, Roozbeh Nazari, Pouya Ebrahimi, Hamidreza Soleimani, Maryam Taheri, Kaveh Hosseini, Homa Taheri, Robert J. Siegel   +7 more
doaj   +1 more source

End-Stage Renal Disease in Familial Amyloidosis ATTR Val30Met: A [PDF]

, 2003
Transplant Proc. 2003 May;35(3):1116-20. End-stage renal disease in familial amyloidosis ATTR Val30Met: a definitive indication to combined liver-kidney transplantation.
Beirão, I., Henriques, A.C., Lobato, L., Miranda, H.P., Pereira, M.C., Sarmento, A.M., Seca, R., Teixeira, M., Ventura, A.   +8 more
core  

Progress in RNA‐Targeted Therapeutics for Human Diseases

MedComm, Volume 7, Issue 2, February 2026.
RNA‐targeted therapies are revolutionizing molecular medicine by transitioning from a “protein‐centric” focus to an “RNA‐regulatory network” approach. Leveraging RNA's diverse roles in gene regulation, signaling, and epigenetic modifications, advanced platforms such as ASOs, siRNA, miRNA, mRNA, aptamers, shRNA, and CRISPR/Cas systems are enabling ...
Wangzheqi Zhang, Aimin Jiang, Bin‐Kui Jia, Yuming Jin, Yinghu Chen, Zhaoyu Li, Yan Liao, Haoling Zhang, Zhiheng Lin, Xiao Fang, Linhui Wang   +10 more
wiley   +1 more source

Cardiac amyloidosis in a Swiss autopsy cohort – distribution and clinical relevance

Swiss Medical Weekly
AIMS: Cardiac amyloidosis (CA) characterised by myocardial amyloid accumulation is likely underdiagnosed. The distribution and extent of myocardial amyloid deposits remain unclear.
Albert Baschong, Sara Ersözlü, Frank Ruschitzka, Andreas J. Flammer, Christoph A. Meier, Zsuzsanna Varga, Holger Moch, Umberto Maccio   +7 more
doaj   +1 more source

Bidirectional crusher gradient method to estimate the labeling efficiency of pseudo‐continuous arterial spin labeling MRI in mice

Magnetic Resonance in Medicine, Volume 95, Issue 2, Page 912-926, February 2026.
Abstract Purpose To develop an experimental method for measuring the labeling efficiency of pseudo‐continuous arterial spin labeling (pCASL) MRI in mice. Methods We propose a method using bidirectional crusher gradients to modulate vascular signals in the azygos pericallosal artery (azPA) of the mouse brain, applied with and without pCASL labeling. The
Xiuli Yang, Yuguo Li, Adnan Bibic, Maria Guadalupe Mora Alvarez, Hanzhang Lu, Zhiliang Wei   +5 more
wiley   +1 more source

Outcomes of heart failure with preserved ejection fraction (HFpEF) in patients with and without cardiac amyloidosis: analysis from 2016–2019 national inpatient sample [PDF]

, 2022
Soumya Kambalapalli, Nischit Baral, Amith Reddy Seri, S Bhakta   +3 more
openalex   +1 more source

Cryoglobulinemia: An update on classification, pathophysiology, clinical presentation, and management

Journal of Internal Medicine, Volume 299, Issue 2, Page 196-215, February 2026.
Abstract Cryoglobulinemia (CG) is defined by the presence of serum immunoglobulins that precipitate below 37°C and redissolve upon rewarming. It is classified into three types based on immunoglobulin composition. Type I, a rare form, involves monoclonal IgM or IgG and is linked to lymphoproliferative disorders.
Anna Linda Zignego, Laura Gragnani, Marcella Visentini, Riccardo Bomben, Luca Arcaini, Clodoveo Ferri, Valter Gattei, Cesare Mazzaro   +7 more
wiley   +1 more source

Cardiac Amyloidosis: A Narrative Review of Diagnostic Advances and Emerging Therapies

Biomedicines
Background/Objectives: Cardiac amyloidosis (CA) is an underdiagnosed and potentially life-threatening infiltrative cardiomyopathy characterized by the extracellular deposition of misfolded amyloid fibrils in cardiac tissue. It is most commonly associated
Dana Emilia Movila, Alexandru Catalin Motofelea, Dragos Cozma, Oana Albai, Alexandra Christa Sima, Minodora Andor, Tudor Ciocarlie, Simona Ruxanda Dragan   +7 more
doaj   +1 more source